Kukje Pharma Co., Ltd. (KRX:002720)
3,435.00
+50.00 (1.48%)
Sep 1, 2026, 3:30 PM KST
-26.91% (1Y)
| Market Cap | 68.93B -28.0% |
| Revenue (ttm) | 181.27B +8.0% |
| Net Income | 5.00B -21.5% |
| EPS | 240.18 -23.6% |
| Shares Out | 20.36M |
| PE Ratio | 14.09 |
| Forward PE | n/a |
| Dividend | 30.00 (0.92%) |
| Ex-Dividend Date | Mar 12, 2026 |
| Volume | 183,594 |
| Open | 3,350.00 |
| Previous Close | 3,385.00 |
| Day's Range | 3,310.00 - 3,580.00 |
| 52-Week Range | 2,810.00 - 5,470.00 |
| Beta | 0.25 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |